NCT05300321View on ClinicalTrials.gov

DIMS-myopia Progression ADN Axial Length Growth

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

April 1, 2021

Conditions
Myopia, Progressive
Interventions
DEVICE

frame lens

The subjects were randomized to allocate in Single Vision (SV) lens or Defocus Incorporated Multiple Segments (DIMS) Lens group.

Trial Locations (1)

Unknown

Tianjin Eye Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Eye Hospital

OTHER

NCT05300321 - DIMS-myopia Progression ADN Axial Length Growth | Biotech Hunter | Biotech Hunter